Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M506485200 on August 12, 2005

J. Biol. Chem., Vol. 280, Issue 40, 33735-33738, October 7, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/40/33735    most recent
M506485200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lahiri, S.
Right arrow Articles by Futerman, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lahiri, S.
Right arrow Articles by Futerman, A. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

LASS5 Is a Bona Fide Dihydroceramide Synthase That Selectively Utilizes Palmitoyl-CoA as Acyl Donor*

Sujoy Lahiri and Anthony H. Futerman1

From the Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel

We demonstrated recently (Riebeling, C., Allegood, J.C., Wang, E., Merrill, A. H. Jr., and Futerman, A. H. (2003) J. Biol. Chem. 278, 43452–43459) that upon over-expression in human embryonic kidney cells, longevity assurance gene homolog 5 (LASS5, previously named TRH4) elevates the synthesis of (dihydro)ceramides selectively enriched in palmitic acid. To determine whether LASS5 is a bona fide dihydroceramide synthase or, alternatively, whether it modifies an endogenous dihydroceramide synthase, we over-expressed LASS5 with a hemagglutinin (HA) tag at the C terminus, solubilized it using digitonin, and purified it by immunoprecipitation. Solubilized LASS5-HA displays the same fatty acid selectivity as the membrane-bound enzyme. After elution from agarose beads, only one band could be detected by SDS-PAGE, and its identity was confirmed to be LASS5 by mass spectrometry. Dihydroceramide synthase activity of the eluted LASS5-HA protein was totally dependent on exogenously added phospholipids. Moreover, eluted LASS5-HA was highly selective toward palmitoyl-CoA as acyl donor and was inhibited by the (dihydro)ceramide synthase inhibitor, fumonisin B1. This study identifies LASS5 as a genuine dihydroceramide synthase and demonstrates that mammalian dihydroceramide synthases do not require additional subunits for their activity.


Received for publication, June 14, 2005

* This work was supported by Israel Science Foundation Grant 1047/03. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Joseph Meyerhoff Professor of Biochemistry. To whom correspondence should be addressed: Dept. of Biological Chemistry, Weizmann Inst. of Science, Rehovot 76100, Israel. Tel.: 972-8-9342704; Fax: 972-8-9344112; E-mail: tony.futerman{at}weizmann.ac.il.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Lahiri, H. Park, E. L. Laviad, X. Lu, R. Bittman, and A. H. Futerman
Ceramide Synthesis Is Modulated by the Sphingosine Analog FTY720 via a Mixture of Uncompetitive and Noncompetitive Inhibition in an Acyl-CoA Chain Length-de pend ent Manner
J. Biol. Chem., June 12, 2009; 284(24): 16090 - 16098.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Kyogashima, K. Tadano-Aritomi, T. Aoyama, A. Yusa, Y. Goto, K. Tamiya-Koizumi, H. Ito, T. Murate, R. Kannagi, and A. Hara
Chemical and Apoptotic Properties of Hydroxy-Ceramides Containing Long-Chain Bases with Unusual Alkyl Chain Lengths
J. Biochem., July 1, 2008; 144(1): 95 - 106.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Rabionet, A. C. van der Spoel, C.-C. Chuang, B. von Tumpling-Radosta, M. Litjens, D. Bouwmeester, C. C. Hellbusch, C. Korner, H. Wiegandt, K. Gorgas, et al.
Male Germ Cells Require Polyenoic Sphingolipids with Complex Glycosylation for Completion of Meiosis: A LINK TO CERAMIDE SYNTHASE-3
J. Biol. Chem., May 9, 2008; 283(19): 13357 - 13369.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Laviad, L. Albee, I. Pankova-Kholmyansky, S. Epstein, H. Park, A. H. Merrill Jr., and A. H. Futerman
Characterization of Ceramide Synthase 2: TISSUE DISTRIBUTION, SUBSTRATE SPECIFICITY, AND INHIBITION BY SPHINGOSINE 1-PHOSPHATE
J. Biol. Chem., February 29, 2008; 283(9): 5677 - 5684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Mesika, S. Ben-Dor, E. L. Laviad, and A. H. Futerman
A New Functional Motif in Hox Domain-containing Ceramide Synthases: IDENTIFICATION OF A NOVEL REGION FLANKING THE Hox AND TLC DOMAINS ESSENTIAL FOR ACTIVITY
J. Biol. Chem., September 14, 2007; 282(37): 27366 - 27373.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Min, A. Mesika, M. Sivaguru, P. P. Van Veldhoven, H. Alexander, A. H. Futerman, and S. Alexander
(Dihydro)ceramide Synthase 1 Regulated Sensitivity to Cisplatin Is Associated with the Activation of p38 Mitogen-Activated Protein Kinase and Is Abrogated by Sphingosine Kinase 1
Mol. Cancer Res., August 1, 2007; 5(8): 801 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Baran, A. Salas, C. E. Senkal, U. Gunduz, J. Bielawski, L. M. Obeid, and B. Ogretmen
Alterations of Ceramide/Sphingosine 1-Phosphate Rheostat Involved in the Regulation of Resistance to Imatinib-induced Apoptosis in K562 Human Chronic Myeloid Leukemia Cells
J. Biol. Chem., April 13, 2007; 282(15): 10922 - 10934.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. E. Senkal, S. Ponnusamy, M. J. Rossi, J. Bialewski, D. Sinha, J. C. Jiang, S. M. Jazwinski, Y. A. Hannun, and B. Ogretmen
Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas
Mol. Cancer Ther., February 1, 2007; 6(2): 712 - 722.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kitatani, J. Idkowiak-Baldys, J. Bielawski, T. A. Taha, R. W. Jenkins, C. E. Senkal, B. Ogretmen, L. M. Obeid, and Y. A. Hannun
Protein Kinase C-induced Activation of a Ceramide/Protein Phosphatase 1 Pathway Leading to Dephosphorylation of p38 MAPK
J. Biol. Chem., December 1, 2006; 281(48): 36793 - 36802.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Spassieva, J.-G. Seo, J. C. Jiang, J. Bielawski, F. Alvarez-Vasquez, S. M. Jazwinski, Y. A. Hannun, and L. M. Obeid
Necessary Role for the Lag1p Motif in (Dihydro)ceramide Synthase Activity
J. Biol. Chem., November 10, 2006; 281(45): 33931 - 33938.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Pewzner-Jung, S. Ben-Dor, and A. H. Futerman
When Do Lasses (Longevity Assurance Genes) Become CerS (Ceramide Synthases)?: INSIGHTS INTO THE REGULATION OF CERAMIDE SYNTHESIS
J. Biol. Chem., September 1, 2006; 281(35): 25001 - 25005.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement